Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $65.36 million. The enterprise value is $94.31 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 139.07 million shares outstanding. The number of shares has increased by 5.42% in one year.
| Current Share Class | 139.07M |
| Shares Outstanding | 139.07M |
| Shares Change (YoY) | +5.42% |
| Shares Change (QoQ) | +17.14% |
| Owned by Insiders (%) | 7.25% |
| Owned by Institutions (%) | 3.43% |
| Float | 37.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| Forward PS | 0.49 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 2.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.82.
| Current Ratio | 2.35 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.90 |
Financial Efficiency
Return on equity (ROE) is -34.88% and return on invested capital (ROIC) is -9.86%.
| Return on Equity (ROE) | -34.88% |
| Return on Assets (ROA) | -8.09% |
| Return on Invested Capital (ROIC) | -9.86% |
| Return on Capital Employed (ROCE) | -18.50% |
| Revenue Per Employee | $505,461 |
| Profits Per Employee | -$70,901 |
| Employee Count | 232 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, XTNT has paid $187,000 in taxes.
| Income Tax | 187,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.83% in the last 52 weeks. The beta is 0.41, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -59.83% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 0.57 |
| Relative Strength Index (RSI) | 45.54 |
| Average Volume (20 Days) | 38,027 |
Short Selling Information
The latest short interest is 64,732, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 64,732 |
| Short Previous Month | 91,281 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.17% |
| Short Ratio (days to cover) | 0.46 |
Income Statement
In the last 12 months, XTNT had revenue of $117.27 million and -$16.45 million in losses. Loss per share was -$0.12.
| Revenue | 117.27M |
| Gross Profit | 68.22M |
| Operating Income | -12.07M |
| Pretax Income | -4.95M |
| Net Income | -16.45M |
| EBITDA | -7.85M |
| EBIT | -12.07M |
| Loss Per Share | -$0.12 |
Full Income StatementBalance Sheet
The company has $6.20 million in cash and $35.14 million in debt, giving a net cash position of -$28.94 million or -$0.21 per share.
| Cash & Cash Equivalents | 6.20M |
| Total Debt | 35.14M |
| Net Cash | -28.94M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 42.96M |
| Book Value Per Share | 0.31 |
| Working Capital | 38.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$11.90 million and capital expenditures -$4.11 million, giving a free cash flow of -$16.01 million.
| Operating Cash Flow | -11.90M |
| Capital Expenditures | -4.11M |
| Free Cash Flow | -16.01M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 58.17%, with operating and profit margins of -10.30% and -14.03%.
| Gross Margin | 58.17% |
| Operating Margin | -10.30% |
| Pretax Margin | -13.87% |
| Profit Margin | -14.03% |
| EBITDA Margin | -6.69% |
| EBIT Margin | -10.30% |
| FCF Margin | n/a |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.42% |
| Shareholder Yield | -5.42% |
| Earnings Yield | -25.17% |
| FCF Yield | -24.49% |
Analyst Forecast
The average price target for XTNT is $3.00, which is 538.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 538.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 0.08333:1.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.08333:1 |
Scores
XTNT has an Altman Z-Score of -1.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.37 |
| Piotroski F-Score | 2 |